Floatz logo

84 assets in T-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing T-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fludarabine
T-Cell Non-Hodgkin Lymphoma
GC Cell CorporationP2BBB (74)
Brentuximab Vedotin
T-Cell Non-Hodgkin Lymphoma
Yale UniversityP4BBB (73)
Cyclophosphamide
T-Cell Non-Hodgkin Lymphoma
GC Cell CorporationP3BB (70)
Rituximab
T-Cell Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP2BB (70)
Tacrolimus
T-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2BB (69)
Busulfanum
T-Cell Non-Hodgkin Lymphoma
Sichuan UniversityP3BB (68)
Melphalan
T-Cell Non-Hodgkin Lymphoma
Sichuan UniversityP3BB (68)
cd7.car/28zeta car t cells
T-Cell Non-Hodgkin Lymphoma
Baylor College of MedicineP2BB (66)
Cytarabine
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP3BB (66)
Dexasone
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP3BB (66)
Romidepsin
T-Cell Non-Hodgkin Lymphoma
Sichuan UniversityP3BB (66)
Tucidinostat
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Xiamen UniversityP3BB (66)
Pembrolizumab
T-Cell Non-Hodgkin Lymphoma
Yale UniversityP2BB (65)
Azacitidine
T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (64)
Bendamustine
T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer CenterP2BB (64)
Etoposide
T-Cell Non-Hodgkin Lymphoma
Yale UniversityP3BB (64)
Pralatrexate
T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer CenterP3BB (64)
(+)-Vincristine
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP3BB (64)
Bortezomib
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2B (62)
Camustine
T-Cell Non-Hodgkin Lymphoma
Sichuan UniversityP3B (62)
Soquelitinib
T-Cell Non-Hodgkin Lymphoma
Corvus Pharmaceuticals, Inc.P3B (62)
Clofarabine
T-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2B (61)
Sirolimus
T-Cell Non-Hodgkin Lymphoma
Masonic Cancer Center, University of MinnesotaP2B (61)
Nivolumab
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Bengbu Medical UniversityP2B (60)
Ruxolitinib
T-Cell Non-Hodgkin Lymphoma
Jonathan BrammerP2B (59)
Belinostat
T-Cell Non-Hodgkin Lymphoma
Corvus Pharmaceuticals, Inc.P3B (58)
cd19-ucart
T-Cell Non-Hodgkin Lymphoma
Beijing GoBroad HospitalP1/2B (58)
Hydrocortisone
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2B (58)
Venetoclax
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2B (58)
Vorinostat
T-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2B (58)
Cladribine
T-Cell Non-Hodgkin Lymphoma
Sichuan UniversityP3B (57)
Methotrexate
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2B (57)
Duvelisib
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Xiamen UniversityP2CCC (55)
cd5-targeted car-t cells
T-Cell Non-Hodgkin Lymphoma
Beijing GoBroad HospitalP1/2CCC (54)
Allopurinol
T-Cell Non-Hodgkin Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Auto Car T Cell Therapy
T-Cell Non-Hodgkin Lymphoma
Autolus LimitedP2CCC (53)
Calaspargase Pegol
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CCC (53)
Dasatinib
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CCC (53)
Daunomycin
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CCC (53)
Enasidenib
T-Cell Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Genetic: Mb-105
T-Cell Non-Hodgkin Lymphoma
March Biosciences IncP2CCC (53)
Humanized Cd7 Car-T Cells
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow UniversityP2CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Mercaptopurine Anhydrous
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CCC (53)
Mgta-456
T-Cell Non-Hodgkin Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Mogamulizumab
T-Cell Non-Hodgkin Lymphoma
Yale UniversityP2CCC (53)
Thioguanine Anhydrous
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CCC (53)
Nelarabine
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CCC (52)
ctx131
T-Cell Non-Hodgkin Lymphoma
CRISPR TherapeuticsP1/2CCC (50)
Golidocitinib
T-Cell Non-Hodgkin Lymphoma
Dizal PharmaceuticalsP1/2CCC (48)
Showing 1 to 50 of 84 assets
PreviousPage 1 of 2Next